- Home
- PCVX vs CELH Comparison
PCVX vs CELH Comparison
Compare PCVX & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | CELH |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 10.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PCVX | CELH |
|---|---|---|
| Price | $54.75 | $55.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 18 |
| Target Price | ★ $105.00 | $63.71 |
| AVG Volume (30 Days) | 1.1M | ★ 4.1M |
| Earning Date | 02-24-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.13 |
| Revenue | N/A | ★ $2,125,838,000.00 |
| Revenue This Year | N/A | $83.09 |
| Revenue Next Year | N/A | $32.27 |
| P/E Ratio | ★ N/A | $433.92 |
| Revenue Growth | N/A | ★ 55.07 |
| 52 Week Low | $27.66 | $21.10 |
| 52 Week High | $93.77 | $66.74 |
Technical Indicators
Market Signals| Indicator | PCVX | CELH |
|---|---|---|
| Relative Strength Index (RSI) | 71.40 | 67.55 |
| Support Level | $50.70 | $54.71 |
| Resistance Level | $56.04 | $57.30 |
| Average True Range (ATR) | 2.68 | 2.13 |
| MACD | 0.87 | 0.16 |
| Stochastic Oscillator | 90.60 | 73.28 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.